Urinalysis Market To Reach US$ 1,779.9 Million By 2027 - Coherent Market Insights

 

A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine.

The global urinalysis market is estimated to account for US$ 1,249.0 Mn in terms of value and is expected to reach US$ 1,779.9 Mn by the end of 2027.

Global Urinalysis Market: Drivers

Approval and launch of new products is expected to propel growth of the global urinalysis market over the forecast period. For instance, in January 2019, Bio-Rad Laboratories, Inc. launched, qUAntify Advance Control, an independent quality control used in clinical labs while performing urine test.

Global Urinalysis Market: Opportunities

Adoption of electronic nose in urinalysis is expected to offer lucrative growth opportunities for players in the global urinalysis market. For instance, in May 2020, researchers from Vrije Universiteit Amsterdam, The Netherlands, reported that in an intention-to-diagnose high-risk pediatric population, urinary tract infections could be discriminated from non- urinary tract infection by volatile organic compounds profiling, using an electronic nose.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/382

Global Urinalysis Market: Restraints

Laboratory staff shortage is expected to hinder growth of the global urinalysis market. Such scenario is majorly present in emerging economies.

Key Takeaways:

The global urinalysis market was valued at US$ 1,183.7 Mn in 2019 and is forecast to reach a value of US$ 1,779.9 Mn by 2027 at a CAGR of 5.2% between 2020 and 2027. Major factor driving the growth of global Urinalysis market during the forecast period include increasing prevalence of kidney diseases, and increasing geriatric population.

Consumables held dominant position in the global urinalysis market in 2019, accounting for 67.5% share in terms of volume, followed by Instruments. Increasing test volume is expected to support growth of the consumables segment over the forecast period.

Market Trends

High prevalence of urinary tract infections is expected to propel growth of the global urinalysis market. For instance, according to the study “Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda”, published in February 2019, the prevalence of urinary tract infections was 32.2% among the study.   

Major players in the global urinalysis market are focused on adopting partnership strategies to enhance their market share. For instance, in August 2020, Sysmex America, Inc. announced an exclusive agreement with Siemens Healthineers that grants North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/urinalysis-market-382

Global Urinalysis Market: Competitive Landscape  

Major players operating in the global urinalysis market include, e Alere, Bio-Rad Laboratories, Inc., Roche Diagnostics, Mindray, Healthy.io, Arkray, Inc., Sysmex America, Inc., Beckman Coulter, and Siemens Healthcare.

Global Urinalysis Market: Key Developments

Major players in the global urinalysis market are focused on raising funds to expand their product portfolio. For instance, in September 2019, Healthy.io raised US$ 60 million in a Series C funding round led by Corner Ventures.

Major players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in 2018, Beckman Coulter and U.S. Arkray, Inc., announced a partnership and introduced iQ Urinalysis Workcell, an automated urine analyzers in the US.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/382

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

Urinalysis Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2024

A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems.  A urine test includes three parts namely, visual exam, microscopic exam, and dipstick test. Its primary aim is to screen health conditions. The urinalysis is carried out as routine medical checkup, pregnancy check-up, pre-surgery preparation, or on hospital admission to treat various disorders. It may be used to screen for and/or help diagnose conditions such as a kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions, to name a few. Additional tests and clinical valuation are often required to further examine findings of urinalysis and finally diagnose the causes or specific features of core problems. For example, urine infection is generally identified based on results of urinalysis. Urine culture is frequently ordered as a follow-up test to recognize the bacteria that may be causing the infection.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/382

According to Centers for Disease Control and Prevention, as of 2016, around 4.9 million people in the U.S. are diagnosed with kidney disease. The major factors that are driving the growth of market are escalating prevalence of kidney diseases and urinary tract infections, technological advancements, increasing adoption rate of point-of-care urinalysis devices, implementation of Patient Protection and Affordable Care Act (PPACA), increasing healthcare expenditure and increasing senior citizen population.

Urinalysis Market

On the basis of product type, the urinalysis market is classified into the following:

• Consumables
• Instruments

On the basis of test type, the urinalysis market is classified into following:

• Biochemical Urinalysis
• Sediment Urinalysis

On the basis of end user, the urinalysis market is classified into following:

• Hospitals
• Diagnostics Laboratories
• Research Laboratories and Institutes
• Home-care Settings

Urinalysis Market Dynamics

According to Centers for Disease Control and Prevention (CDC), diabetes is one of the most common chronic diseases among humans, around 29.1 million people or 9.3% of the U.S population suffers from diabetes (2016). Increase in the prevalence of chronic diseases and geriatric population will give rise to prevention and cure for the chronic diseases, owing to the growth of urinalysis market. Emergence of portable and battery operated urinalysis devices and increase in implementation of urinalysis in emerging economic countries such as China, India and others, will create new opportunities for the urinalysis market. Integrated systems & urinalysis via smartphones and technological advancement present opportunities in the market.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/urinalysis-market-382

High costs of R&D, implementation of excise tax by the U.S. government and stringent regulatory procedures are major factors that hinder the growth of the market. The large target population and the observed high, unmet clinical needs in the developing regions provide the market with a large pool of opportunities for prospective growth. To exploit on these opportunities, the development of diagnostic tools that can respond to these unmet clinical needs at reasonable price is mandatory.

Regional Analysis

North America is the largest region in the urinalysis market. The major driver for the large market share includes presence of key market players in the region such as Alere, Inc., Bio Rad, Siemens Healthcare, and Beckman Coulter. Moreover, introduction of the automated urine sediment analyzers such as digital flow morphology (digital imaging) & fluorescence flow cytometry together with high healthcare expenditure in this region. Asia Pacific is expected to observe the fastest growth during the forecast period. Increasing penetration rate of advanced urine analyzers, and the presence of local urine analyzer manufacturers, such as Mindray, Urit medical, and a large base of the target population with unmet clinical needs are expected to strengthen the market growth over the forecast period.

Key players operating in the urinalysis market are Alere, Bio Rad, Roche Diagnostics, Mindray, Arkray, Inc., Sysmex, and Siemens Healthcare.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.